Dr. Rizvi on the Utility of Trastuzumab Deruxtecan in NSCLC
Naiyer A. Rizvi, MD, discusses the utility of fam-trastuzumab deruxtecan-nxki in non–small cell lung cancer.
Dr. Pennell on Remaining Challenges in NSCLC
Nathan A. Pennell, MD, PhD, discusses remaining challenges in non–small cell lung cancer.
Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation
Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis
Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment
First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma
2 Clarke Drive Cranbury, NJ 08512